COSMOS Pharmaceutical Corporation

TSE:3349 Stock Report

Market Cap: JP¥573.2b

COSMOS Pharmaceutical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Hideaki Yokoyama

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.7yrs
CEO ownership0.008%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

COSMOS Pharmaceutical Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Apr 17
COSMOS Pharmaceutical Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Some Shareholders Feeling Restless Over COSMOS Pharmaceutical Corporation's (TSE:3349) P/E Ratio

Mar 16
Some Shareholders Feeling Restless Over COSMOS Pharmaceutical Corporation's (TSE:3349) P/E Ratio

Returns On Capital At COSMOS Pharmaceutical (TSE:3349) Paint A Concerning Picture

Feb 28
Returns On Capital At COSMOS Pharmaceutical (TSE:3349) Paint A Concerning Picture

CEO

Hideaki Yokoyama (43 yo)

6.7yrs

Tenure

Mr. Hideaki Yokoyama has been President at COSMOS Pharmaceutical Corporation since June 2018 and served as its General Manager of Sales Division and Head of Store Operations since August 2017. Mr. Yokoyama...


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.